News & Events

Events

Upcoming Events »

August 11, 2010 10:30 am: ProMetic conference call / web cast - Q2 2010
An audio replay of the call will be available for a period of seven days as of Wednesday, August 11, 2010, at 13:00 (EDT). The number to access the audio replay is 1 (866) 583-1035 using access code 8025830#. The replay of the web cast may be downloaded directly through the link below.
» Webcast
» ProMetic Q2 2010 Presentation (PDF : 5.46 Mb)
May 18, 2010 06:55 am: 6th Annual Rodman & Renshaw Global Health Care Conference
London, England
» Webcast
May 5, 2010 10:30 am: Annual and Special Meeting of ProMetic Shareholders
Montreal, Quebec
» Webcast
» ProMetic Presentation AGM 2010 (PDF : 15.91 Mb)
March 31, 2010 10:30 am: ProMetic conference call / web cast - Year End 2009
» Webcast
» Presentation (PDF : 1.11 Mb)
January 12, 2010 11:40 am: ProMetic presentation at Biotech Showcase 2010
San Francisco, California
» Presentation - Biotech Showcase 2010 (PDF : 999 Kb)
September 9, 2009 11:40 am: Rodman & Renshaw's 11th Annual Healthcare Conference
New York, New York
» Webcast
» 2009-09-09 ProMetic Rodman & Renshaw (PDF : 795 Kb)
March 2 - 5, 2009 02:00 pm: 3rd Annual Conference PrPCANADA 2009
Edmonton, Alberta, Canada
Presentation titled:
» Development of a Device for Reduction of Prion Infectivity from Red Blood Cell Concentrate (PDF : 610 Kb)
October 8 - 10, 2008: Prion 2008
Madrid, Spain
Presentations titled:
» Reduction of prion from red cells, plasma and plasma products using specific affinity ligands (PDF : 1.27 Mb)
» Specificity and capacity of the P-Capt(R) filter for prion protein and prion infectivity (PDF : 791 Kb)
September 8, 2008 10:00 am: Canal Argent
Canal Argent talks to Pierre Laurin, President & CEO, ProMetic Life Sciences Inc. - in french only
August 20, 2008: Business News Network
BNN talks to Pierre Laurin, President & CEO, ProMetic Life Sciences Inc.
June 22 - 27, 2008: Recovery of Biological Products 13
Quebec City, Quebec, Canada
Presentation titled:
» Removal of prion infectivity from plasma-derived products ( : 474 Kb)
June 14, 2008: 13th Congress of the European Hematology Association
Copenhagen, Denmark
Poster presentation titled:
» PBI-1402 increases hemoglobin level and red blood cell count in chemotherapy-induced anemia (PDF : 171 Kb)
April 22 - 23, 2008: Bioprocess International Europe
Vienna, Austria
April 12 - 16, 2008: American Association for Cancer Research
San Diego, California, United States of America
Poster presentations titled:
» PBI-1308 inhibits inflammation and cancer cell proliferation through inhibition of NF-kB (PDF : 395 Kb)
» Anticancer effect of PBI-0110 in combination with gemcitabine in intradermal and orthotopic pancreatic cancer (PDF : 116 Kb)
April 12 - 16, 2008: American Association for Cancer Research
San Diego, California, United States of America
Poster presentation titled:
» Antitumor activity of PBI-1737 in xenograft human prostate (PC-3) cancer by inhibition of cell adhesion and migration (PDF : 109 Kb)
April 6 - 10, 2008: 235th Annual Chemical Society Meeting
New Orleans, Louisianna, United States of America
Presentation titled:
» Development of a device for prion reduction based on affinity ligand (PDF : 1.17 Mb)
February 4 - 7, 2008: 1st International Conference on Drug Design & Discovery
Dubai, UAE
Presentation titled:
» Triazine Derivatives as Protein A Mimetcs for the Treatment of Autoimmune Disease (PDF : 2.27 Mb)
December 7, 2007: American Society of Hematology 49th Annual Meeting
Atlanta, Georgia, United States of America
Poster presentation titled:
» Oral treatment with PBI-1402 increases hemoglobin level and red blood cell count: A novel approach to treating chemotherapy-induced anemia (PDF : 107 Kb)
November 5 - 7, 2007: Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
New York, NY, USA
October 1 - 4, 2007: BioProcess International™
Boston, Massachusetts, USA
BioProcess International™ is THE meeting place for the bioprocessing industry.
September 24 - 26, 2007: Purification of Biological Products - 3rd Annual meeting
Waltham, Massachusetts, USA
September 16 - 19, 2007: 13th European Congress on Biotechnology
Barcelona, Spain
In line with the European Federation of Biotechnology’s mission, the 13th European Congress on Biotechnology will focus on addressing the great challenges to humanity through the crucial theme of Symbiosis.
September 11 - 13, 2007: European BioPharm Scale-Up Congress
Geneva, Switzerland
European BioPharm Scale-Up Congress is the annual conference experience for the pioneers of the biopharm industry.
August 19 - 23, 2007: American Chemical Society 234th National Meeting & Exposition
Boston, Massachusetts, United States of America
Poster presentation titled:
» 1,3,5-Triazine derivatives with improved solubility for the treatment of inflammatory diseases (PDF : 161 Kb)
June 16 - 20, 2007: 8th World Congress on Inflammation
Copenhagen, Denmark
Poster presentation titled:
» In vitro and in vivo modulatory effect of PBI-1393 on LPS-induced neutrophil activation and inflammatory response (PDF : 96 Kb)
September 10 - 14, 2006: American Chemical Society 232nd National Meeting & Exposition
San Francisco, California, United States of America
Poster presentations titled:
» 1,3,5-Triazine Derivatives as Protein A Mimetics for the Treatment of Autoimmune Diseases (PDF : 197 Kb)